Cargando…

ANLN and KDR Are Jointly Prognostic of Breast Cancer Survival and Can Be Modulated for Triple Negative Breast Cancer Control

Purpose: Kinase insert domain receptor (KDR) is the primary vascular endothelial growth factor receptor mediating survival, growth, and migration of endothelial cells and is expressed also in various tumor cells through autocrine production. The PI3K/Pten pathway is one of the downstream signalings...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dai, Xiaofeng, Mei, Yi, Chen, Xiao, Cai, Dongyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6788326/ https://www.ncbi.nlm.nih.gov/pubmed/31636652 http://dx.doi.org/10.3389/fgene.2019.00790

Ejemplares similares

Genetic interactions between ANLN and KDR are prognostic for breast cancer survival
por: Dai, Xiaofeng, et al.
Publicado: (2019)

Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker
por: Liu, Kejun, et al.
Publicado: (2022)

Male Triple-Negative Breast Cancer
por: Qavi, Qasif, et al.
Publicado: (2021)

Comprehensive bioinformatics analysis reveals the prognostic value, predictive value, and immunological roles of ANLN in human cancers
por: Cui, Zhiwei, et al.
Publicado: (2022)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

ANLN Enhances Triple-Negative Breast Cancer Stemness Through TWIST1 and BMP2 and Promotes its Spheroid Growth
por: Maryam, Alishba, et al.
Publicado: (2021)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Triple negative breast cancer – prognostic factors and survival
por: Ovcaricek, Tanja, et al.
Publicado: (2010)

Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications
por: Liu, Shenting, et al.
Publicado: (2023)

FOXA1 is Prognostic of Triple Negative Breast Cancers by Transcriptionally Suppressing SOD2 and IL6
por: Dai, Xiaofeng, et al.
Publicado: (2019)

Identification of the pyroptosis-related prognostic gene signature and characterization of tumor microenvironment infiltration in triple-negative breast cancer
por: Liu, Ji, et al.
Publicado: (2022)

BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
por: Katheeja, Muhseena N., et al.
Publicado: (2023)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
por: Hu, Shaojun, et al.
Publicado: (2021)

A Combined Nomogram Model to Predict Disease-free Survival in Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy
por: Xia, Bingqing, et al.
Publicado: (2021)

Large miRNA survival analysis reveals a prognostic four-biomarker signature for triple negative breast cancer
por: Andrade, Fernando, et al.
Publicado: (2020)

ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis
por: Xiao, Yu, et al.
Publicado: (2022)

Analysis of single-nucleotide polymorphisms in genes associated with triple-negative breast cancer
por: G., Vigneshwaran, et al.
Publicado: (2022)

Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
por: Escudero Mendez, Lisbeth, et al.
Publicado: (2022)

Identification of Five Cytotoxicity-Related Genes Involved in the Progression of Triple-Negative Breast Cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Effect of N6-Methyladenosine Regulators on Progression and Prognosis of Triple-Negative Breast Cancer
por: Wang, Shanshan, et al.
Publicado: (2021)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
por: Magnusson, Kristina, et al.
Publicado: (2016)

Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)

ANLN Directly Interacts with RhoA to Promote Doxorubicin Resistance in Breast Cancer Cells
por: Wang, Feng, et al.
Publicado: (2020)

MiR-16-5p suppresses breast cancer proliferation by targeting ANLN
por: Wang, Ziming, et al.
Publicado: (2021)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022)

Imaging genetic association analysis of triple-negative breast cancer based on the integration of prior sample information
por: Ning, Shipeng, et al.
Publicado: (2023)

Super enhancer-driven core transcriptional regulatory circuitry crosstalk with cancer plasticity and patient mortality in triple-negative breast cancer
por: Shi, Wensheng, et al.
Publicado: (2023)

Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
por: Lv, Yufei, et al.
Publicado: (2021)

Screening of DNA Damage Repair Genes Involved in the Prognosis of Triple-Negative Breast Cancer Patients Based on Bioinformatics
por: Wang, Nan, et al.
Publicado: (2021)

Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer
por: Zhu, Baoxi, et al.
Publicado: (2022)

Exploring immune interactions in triple negative breast cancer: IL-1β inhibition and its therapeutic potential
por: Wilson, Brooke E., et al.
Publicado: (2023)

Identification of Triple-Negative Breast Cancer Genes and a Novel High-Risk Breast Cancer Prediction Model Development Based on PPI Data and Support Vector Machines
por: Li, Ming, et al.
Publicado: (2019)

Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer
por: Sha, Shengnan, et al.
Publicado: (2022)

Prognostic values of EDNRB in triple-negative breast cancer
por: Liu, Shaoqing, et al.
Publicado: (2020)

KDR Mutation as a Novel Predictive Biomarker of Exceptional Response to Regorafenib in Metastatic Colorectal Cancer
por: Loaiza-Bonilla, Arturo, et al.
Publicado: (2016)

Screening ANLN and ASPM as bladder urothelial carcinoma-related biomarkers based on weighted gene co-expression network analysis
por: Yang, Tenghao, et al.
Publicado: (2023)

Prognosis Prediction Through an Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Data in Triple-Negative Breast Cancer
por: Wang, Xiangru, et al.
Publicado: (2022)

MYBL2 alternative splicing-related genetic variants reduce the risk of triple-negative breast cancer in the Chinese population
por: Chen, Xinyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ftndfvaj4r524bv9nfu5iul86